Jpmorgan Chase & CO Travere Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 748,558 shares of TVTX stock, worth $13.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

748,558

Previous 785,295 4.68%

Holding current value

$13.4 Million

Previous $6.46 Million 62.23%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$7.89 - $15.21 $289,854 - $558,769	-36,737 Reduced 4.68%	748,558 $10.5 Million
Q2 2024 Aug 12, 2024	BUY	$5.26 - $8.28 $2.29 Million - $3.61 Million	436,135 Added 124.91%	785,295 $6.46 Million
Q1 2024 May 10, 2024	SELL	$7.18 - $9.82 $305,552 - $417,899	-42,556 Reduced 10.86%	349,160 $2.69 Million
Q4 2023 Feb 12, 2024	SELL	$5.44 - $9.5 $500,452 - $873,952	-91,995 Reduced 19.02%	391,716 $3.52 Million
Q3 2023 Nov 14, 2023	SELL	$7.64 - $17.25 $1.88 Million - $4.24 Million	-245,697 Reduced 33.68%	483,711 $4.32 Million
Q2 2023 Aug 11, 2023	SELL	$15.3 - $22.61 $6.19 Million - $9.15 Million	-404,743 Reduced 35.69%	729,408 $11.2 Million
Q1 2023 May 18, 2023	BUY	$17.82 - $22.89 $1.4 Million - $1.79 Million	78,362 Added 7.42%	1,134,151 $25.5 Million
Q1 2023 May 11, 2023	SELL	$17.82 - $22.89 $2.98 Million - $3.83 Million	-167,169 Reduced 13.67%	1,055,789 $23.7 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $3.07 Million - $4.34 Million	165,955 Added 15.7%	1,222,958 $25.7 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $937,797 - $1.17 Million	-40,934 Reduced 3.73%	1,057,003 $26 Million
Q2 2022 Aug 11, 2022	BUY	$20.94 - $30.01 $279,946 - $401,203	13,369 Added 1.23%	1,097,937 $26.6 Million
Q1 2022 May 11, 2022	SELL	$23.61 - $30.6 $1.18 Million - $1.53 Million	-49,941 Reduced 4.4%	1,084,568 $27.9 Million
Q4 2021 Feb 10, 2022	BUY	$24.34 - $31.17 $3.85 Million - $4.94 Million	158,369 Added 16.22%	1,134,509 $35.2 Million
Q3 2021 Nov 12, 2021	BUY	$12.98 - $25.03 $12.7 Million - $24.4 Million	976,140 New	976,140 $23.7 Million

Others Institutions Holding TVTX

# of Institutions

193

Shares Held

84.6M

Call Options Held

776K

Put Options Held

900K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.15B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Travere Therapeutics, Inc. Transaction History